PaloVia skin renewing laser makes retail debut
BURLINGTON, Mass. — Palomar Medical Technologies, a researcher and developer of light-based systems for cosmetic treatments, has announced the launch of the first FDA-cleared, at-home laser designed to reduce fine lines and wrinkles around the eyes.
The new PaloVia skin renewing laser works below the skin surface where wrinkles form. It generates pulses of micro-fine laser light that reach deeply into the skin’s sub-layers, treating the skin’s aging support structure, according to the company. Then the body’s natural healing process sweeps away the older, damaged tissue and rebuilds it with new collagen and elastin.
In a clinical study, a panel of doctors specializing in dermatology and plastic surgery saw a "noticeable" reduction in wrinkles in 92% of participants after one month of daily treatments, the company stated.
The PaloVia laser is available for advanced sale through QVC online and will debut on QVC on Dec. 27. The laser will start shipping to consumers in the middle of January, and distribution will be expanded to include Nordstrom, with physicians’ offices and additional retailers coming on board in the first few months of 2011. The product has a suggested retail price of $499.
Elle line at Kohl’s to include cosmetics collection
MENOMONEE FALLS, Wis. — Kohl’s and Lagardere Active are looking to expand the Elle-branded lifestyle collection into cosmetics, as well as fashion jewelry, in spring 2012.
The brand — which initially launched in 2007 and has since expanded from apparel into other categories, including shoes and home goods — will include a line of makeup, skin care, bath and nail products.
The line also will include runway-inspired jewelry, including necklaces, earrings, bracelets and rings.
Former Genentech executive named P&G board member
CINCINNATI — Procter & Gamble on Tuesday afternoon named a healthcare veteran to its board. Susan Desmond-Hellmann, 53, chancellor of the University of California, San Francisco, was named to the board, effective Dec. 13.
"[Desmond-Hellmann’s] breadth of experience in the healthcare industry and leadership within the academic community makes her a strong addition to our board," stated Robert McDonald, P&G chairman, president and CEO. "Her track record is outstanding, and her insights and perspectives will be invaluable." UCSF is dedicated to advancing health worldwide through innovative biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care, P&G noted.
Prior to being named chancellor of UCSF, Desmond-Hellmann served as president of product development at Genentech, a position she held from March 2004 through April 30, 2009. In this role, she was responsible for Genentech’s preclinical and clinical development, process research and development, business development and product portfolio management. During her 14 years at Genentech, several of the company’s patient therapeutics were approved by the Food and Drug Administration, and the company became the nation’s No. 1 producer of anti-cancer drug treatments.
For her outstanding contributions in the healthcare industry, Desmond-Hellmann has received numerous recognitions. In October 2010, she was named to the American Academy of Arts and Sciences and the Institute of Medicine. In November 2009, Forbes magazine named her as one of the world’s seven most "powerful innovators," calling her "a hero to legions of cancer patients." Other recognitions include being named to Fortune magazine’s "Top 50 Most Powerful Women in Business" list in 2001 and from 2003 to 2008.